The Current Ratio as of December 2025 (TTM) for Guard Therapeutics International AB (publ) (GUARD.ST) is 4.87

According to Guard Therapeutics International AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 4.87. This represents a change of 10.15% compared to the average of 4.42 of the last 4 quarters.

Guard Therapeutics International AB (publ) (GUARD.ST) Historical Current Ratio (quarterly & annually)

How has GUARD.ST Current Ratio performed in the past?

The mean historical Current Ratio of Guard Therapeutics International AB (publ) over the last ten years is 6.45. The current 4.87 Current Ratio has changed 7.45% with respect to the historical average. Over the past ten years (40 quarters), GUARD.ST's Current Ratio was at its highest in in the December 2021 quarter at 17.40. The Current Ratio was at its lowest in in the March 2017 quarter at 0.21.

Guard Therapeutics International AB (publ) (GUARD.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Guard Therapeutics International AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Guard Therapeutics International AB (publ) (GUARD.ST) Average Current Ratio

How has GUARD.ST Current Ratio performed in the past?

The current Current Ratio of Guard Therapeutics International AB (publ) (GUARD.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Guard Therapeutics International AB (publ) (GUARD.ST) Current Ratio vs. Peers

How is GUARD.ST’s Current Ratio compared to its peers?

Guard Therapeutics International AB (publ)’s Current Ratio is greater than 2cureX AB (publ) (2.93), greater than Qlife Holding AB (publ) (0.83), greater than Aptahem AB (publ) (1.72), less than Modus Therapeutics Holding AB (publ) (5.98), greater than Fluicell AB (publ) (1.83), greater than Episurf Medical AB (publ) (2.75), greater than Prostatype Genomics AB (publ) (1.95), less than Stayble Therapeutics AB (publ) (7.18), greater than ODI Pharma AB (1.16), greater than Quia Pharma AB (publ) (0.09),

Build a custom stock screener for Guard Therapeutics International AB (publ) (GUARD.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guard Therapeutics International AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Guard Therapeutics International AB (publ) (GUARD.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Guard Therapeutics International AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.